B. Riley Raises Earnings Estimates for Eton Pharmaceuticals
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) – B. Riley lifted their Q4 2025 EPS estimates for shares of Eton Pharmaceuticals in a report issued on Sunday, April 27th. B. Riley analyst M. El-Saadi now expects that the company will post earnings of $0.33 per share for the quarter, up from their prior estimate of […]
